Peyman Moslemy

Title: Peyman Moslemy: Innovator in Ocular Iontophoresis

Introduction

Peyman Moslemy is a notable inventor based in Mansfield, MA (US). He has made significant contributions to the field of ocular drug delivery, particularly through his innovative work in iontophoresis technology. With a total of 2 patents, Moslemy's inventions aim to enhance the effectiveness of therapeutic substances delivered to the eye.

Latest Patents

Moslemy's latest patents focus on a system and method for ocular iontophoresis with buffering. This invention includes compositions, devices, methods of manufacture, and methods of delivery of a therapeutic substance across the surface of an eyeball via iontophoresis. The system features a therapeutic media reservoir and a buffer system within an iontophoretic chamber. When energized, an electrode provides an electromotive force that transfers a dosage of the therapeutic substance from the iontophoretic chamber across the surface of the eyeball. The buffering system is designed to regulate pH during the iontophoretic transfer of the therapeutic substance, utilizing various forms of buffer media such as foam, gel, membrane, and multiparticulates.

Career Highlights

Peyman Moslemy is currently associated with Eyegate Pharmaceuticals, Inc., where he continues to develop innovative solutions for ocular drug delivery. His work has been instrumental in advancing the field and improving patient outcomes.

Collaborations

Moslemy collaborates with talented professionals in his field, including Michael Manzo and William Schubert. Their combined expertise contributes to the success of their projects and the advancement of ocular therapies.

Conclusion

Peyman Moslemy's contributions to ocular iontophoresis represent a significant advancement in the delivery of therapeutic substances to the eye. His innovative patents and collaborations continue to shape the future of ocular medicine.